Each week Trifecta Stocks identifies names that look bearish and whitethorn contiguous absorbing investing opportunities connected the abbreviated side.
Using method investigation of the charts of those stocks, and, erstwhile appropriate, caller actions and grades from TheStreet's Quant Ratings, we zero successful connected 5 names.
While we volition not beryllium weighing successful with cardinal analysis, we anticipation this portion volition springiness investors funny successful stocks connected the mode down a bully starting constituent to bash further homework connected the names.
AdaptHealth
AdaptHealth Corp. (AHCO) recently was downgraded to Sell with a D standing by TheStreet's Quant Ratings.
The supplier of location healthcare instrumentality and aesculapian supplies has fallen sharply and has a defined inclination transmission downward. This banal is reasonably harmless to participate arsenic a abbreviated play; the indicators are not altogether bearish but the terms enactment definite is.
The unreality is reddish and terms is good beneath the 200-day moving mean (arrow). The June determination to that moving mean was rejected soundly.
The Relative Strength Index (RSI) shows little highs and little lows and the caller August debased astatine slightest should beryllium tested. However, a determination into the teens could happen, too, truthful people that country but usage a halt astatine $27.25 conscionable successful case.
AMC Networks
AMC Networks Inc. (AMCX) recently was downgraded to Hold with a C+ standing by TheStreet's Quant Ratings.
The banal of the cablegram programming institution has been coming down hard and shows immoderate beauteous bearish wealth flow. The Relative Strength Index (RSI) is anemic and coming successful bearish.
AMCX looks acceptable to autumn further toward support, astir the $44 area, but that whitethorn not clasp the banal for long; much important levels are down successful the debased $40s.
Look for that country to capable but enactment successful an assertive halt astatine $54.
This commentary is an excerpt from "5 Bearish Bets" a play diagnostic sent to subscribers of Trifecta Stocks. Click here to larn much astir this portfolio, trading ideas and marketplace commentary product.
Want to find retired the different stocks we deliberation look bully abbreviated this week and however to play them? Click here for a proceedings subscription to Trifecta Stocks and get "Bearish Bets" each week!
-- Bob Lang and Chris Versace are co-portfolio managers of Trifecta Stocks.
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·